Gene Therapy Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Gene Therapy 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  l a tes t  repor t  by  IMARC Group ,  t i t l ed  " Gene  Therapy Market :  
G loba l  I ndust ry  T rends ,  Share ,  S ize ,  Grow th ,  Opportun i ty  and  Forecast  2024-
2032, "  t he  g loba l  gene therapy  marke t  s i ze  reached  US$  5 .1  B i l l i on  in  2023.
Gene  the rapy  re fe rs  t o  an  advanced  med ica l  t echn ique  tha t  invo lves  mod i f y ing  
Report t he  genes  ins ide  t he  ce l l s  o f  t he  pa t i en t ' s  body  to  t rea t  o r  p revent  t he  p rogress ion  
o f  t he  d isease.  I t  wo rks  by  rep lac ing  a  de f ec t i ve  gene w i th  a  new,  no rma l  and  
Highlight and hea l thy  gene in  a  ce l l  t o  cu re  the  d isease  or  improve  the  body ' s  ab i l i t y  t o  f i gh t  i t .  
I t  i s  a l so  used  t o  t r ea t  numerous  ch ron ic  and  gene t i c  d isorde rs  i n  human be ings  
tha t  have  no  o the r  cures .  Nowadays ,  manuf ac t u rer s  a re  o f fe r i ng  a  w ide  va r ie t y  o f  
Description gene the rapy  p roduc ts ,  i nc lud ing  p lasmid  deoxy r ibonuc le i c  ac id  (DNA) ,  human 
gene-ed i t i ng  t echno logy ,  pa t ien t -de r i ved  ce l lu la r  gene  the rapy ,  v i r a l  vec to rs ,  and  
bac te r ia l  vec t o r s ,  wh ich  i s  cur ren t l y  esca la t ing  the i r  demand  ac ross  the  g lobe .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/gene- t herapy-marke t / reques tsamp le
Report Description
G l o b a l  G e n e  T h e r a p y  M a r k e t  T r e n d s :
T h e  r i s i n g  p r e v a l e n c e  o f  g e n e t i c  a n d  a c q u i r e d  d i s e a s e s ,  s u c h  a s  c a n c e r ,  d i a b e t e s ,  c a r d i o v a s c u l a r  d i s e a s e s  ( C V D s ) ,  c y s t i c  f i b r o s i s ,  a n d  
a c q u i r e d  i m m u n o d e f i c i e n c y  s y n d r o m e  ( A I D S ) ,  r e p r e s e n t s  t h e  p r i m a r y  f a c t o r  d r i v i n g  t h e  m a r k e t  g r o w t h .  B e s i d e s  t h i s ,  t h e  e x p a n d i n g  
g e r i a t r i c  p o p u l a t i o n  t h a t  i s  m o r e  s u s c e p t i b l e  t o  d e v e l o p i n g  s u c h  c h r o n i c  h e a l t h  c o n d i t i o n s  h a s  c a t a l y z e d  t h e  p r o d u c t  d e m a n d .  
A d d i t i o n a l l y ,  t h e r e  h a s  b e e n  a  s i g n i f i c a n t  i n c r e a s e  i n  g o v e r n m e n t  s u p p o r t  a n d  f u n d i n g  f o r  g e n e  t h e r a p y  r e s e a r c h .  A l o n g  w i t h  t h i s ,  t h e  
g r o w i n g  a w a r e n e s s  r e g a r d i n g  t h e  b e n e f i t s  o f  g e n e  t h e r a p y  a n d  e a s y  a c c e s s i b i l i t y  t o  h e a l t h c a r e  f a c i l i t i e s  h a v e  a c c e l e r a t e d  t h e  p r o d u c t  
a d o p t i o n  r a t e .  F u r t h e r m o r e ,  s e v e r a l  k e y  p l a y e r s  a r e  e n g a g i n g  i n  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  a n d  m a k i n g  h e a v y  
i n v e s t m e n t s  t o w a r d  p r o d u c t  i n n o v a t i o n s  t o  g a i n  a  c o m p e t i t i v e  e d g e .  
M o r e o v e r ,  t h e  i n t r o d u c t i o n  o f  n e w  g e n e  t h e r a p y  t h a t  p r o v i d e s  a  s a f e r  a n d  n o n - a d d i c t i v e  a l t e r n a t i v e  t o  o p i o i d s  i n  t r e a t i n g  v a r i o u s  
c h r o n i c  p a i n  c o n d i t i o n s ,  s u c h  a s  l o w e r  b a c k  p a i n  a n d  r a r e  n e u r o p a t h i c  p a i n  d i s o r d e r s ,  h a s  p r o p e l l e d  t h e  m a r k e t  g r o w t h .  O t h e r  f a c t o r s ,  
i n c l u d i n g  t h e  i n c r e a s i n g  a p p r o v a l s  o f  g e n e  t h e r a p y  p r o d u c t s ,  f a v o r a b l e  r e i m b u r s e m e n t  p o l i c i e s ,  i m p r o v i n g  h e a l t h c a r e  i n f r a s t r u c t u r e ,  
r i s i n g  c o n s u m e r  h e a l t h c a r e  e x p e n d i t u r e ,  a n d  t e c h n o l o g i c a l  a d v a n c e m e n t s ,  a r e  a l s o  p r o v i d i n g  a  p o s i t i v e  i m p a c t  o n  t h e  m a r k e t  g r o w t h .
L o o k i n g  f o r w a r d ,  I M A R C  G r o u p  e x p e c t s  t h e  m a r k e t  t o  r e a c h  U S $  1 6 . 8  B i l l i o n  b y  2 0 3 2 ,  g r o w i n g  a t  a  C A G R  o f  1 3 . 9 %  d u r i n g  2 0 2 4 -
2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / g e n e - t h e r a p y - m a r k e t
Breakup by Gene Type:
• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Defi ciency
• Growth Factors
Report • Receptors
• Others
Segmentation
Breakup by Vector Type:
• Viral  Vector
o Adenoviruses
o Lentiv iruses
o Retroviruses
o Adeno-Associated Virus
o Herpes Simplex Virus
o Poxvirus
o Vaccinia Virus
o Others
• Non-Viral  Techniques
o Naked and Plasmid Vectors
Report o Gene Gun
o
Segmentation Electroporat ion
o Lipofection
o Others
Breakup by Delivery Method:
• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy
Breakup by Application:
• Oncological  Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological  Disorders
• Infect ious Disease
Report • Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Abeona Therapeutics Inc.
• Adaptimmune Therapeutics plc
• Adverum Biotechnologies Inc.
• Amgen Inc.
Competitive 
• Astel las Pharma Inc.
Landscape • Biogen Inc.
with Key • Bluebird Bio Inc.
• Mustang Bio Inc. (Fortress Biotech Inc.)
Players
• Novart is AG
• Orchard Therapeutics plc
• UniQure N.V.
• Voyager Therapeutics Inc.
How big is the global gene therapy market?
What is the expected growth rate of the global 
gene therapy market during 2024-2032?
What are the key factors driving the global gene 
Key therapy market?
Questions What has been the impact of COVID-19 on the 
global gene therapy market?
Answered in 
What is the breakup of the global gene therapy 
the Report market based on the vector type?
What is the breakup of the global gene therapy 
market based on the application?
What are the key regions in the global gene 
therapy market?
Who are the key players/companies in the global 
gene therapy market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  G e n e  T h e r a p y  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  G e n e  T y p e
    6 . 1     A n t i g e n
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C y t o k i n e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     T u m o r  S u p p r e s s o r
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     S u i c i d e  G e n e
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     D e f i c i e n c y
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     G r o w t h  F a c t o r s
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t
    6 . 7     R e c e p t o r s
        6 . 7 . 1  M a r k e t  T r e n d s
Table of         6 . 7 . 2  M a r k e t  F o r e c a s t    6 . 8     O t h e r s
        6 . 8 . 1  M a r k e t  T r e n d s
        6 . 8 . 2  M a r k e t  F o r e c a s t
Contents 7    M a r k e t  B r e a k u p  b y  V e c t o r  T y p e    7 . 1     V i r a l  V e c t o r
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  K e y  S e g m e n t s
           7 . 1 . 2 . 1  A d e n o v i r u s e s
           7 . 1 . 2 . 2  L e n t i v i r u s e s
           7 . 1 . 2 . 3  R e t r o v i r u s e s
           7 . 1 . 2 . 4  A d e n o - A s s o c i a t e d  V i r u s
           7 . 1 . 2 . 5  H e r p e s  S i m p l e x  V i r u s
           7 . 1 . 2 . 6  P o x v i r u s
           7 . 1 . 2 . 7  V a c c i n i a  V i r u s
                 7 . 1 . 2 . 8  O t h e r s
            7 . 1 .3  M a r ke t  Fo rec a s t
      7 .2       N o n -V i r a l  Te ch n iq u es
            7 . 2 .1  M a r ke t  Tren d s     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / g en e - t h e r a p y - m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]